Joseph S Konowiecki Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days ago
Joseph S Konowiecki has an estimated net worth of at least $15.6 million*, as of Nov. 13, 2024. They own 1.1 million shares of ALHC stock. They have sold 128,231 shares of ALHC stock since 2021, for an estimated $612,013.
Joseph S Konowiecki $ALHC SEC Form 4 Insider Trading
Joseph S Konowiecki has filed a total of 10 insider trades in $ALHC since 2021. Their most recent trade was a sale of 6,920 shares, made on Nov 11, 2024. Their largest trade was a purchase of 100,000 shares, made on Mar 09, 2023. We estimate that they now own 1.1 million shares of $ALHC, worth an estimated $15.0 million.
Insider Trading at $ALHC
There have been a total of 193 insider trades reported at $ALHC since 2021, with 203,000 shares purchased and 48.9 million shares sold. The most active insider traders in $ALHC stock have been Robert Thomas Freeman, Dawn Christine Maroney, and John E Kao. The most recent trade was a sale of 30,000 shares reported by Dawn Christine Maroney (President, Markets), made on Nov 15, 2024.
History of Insider Stock Trades by Joseph S Konowiecki
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ALHC
|
Sale | 6,920 | Nov 11, 2024 | Nov. 13, 2024, 6:18 p.m. |
|
ALHC
|
Sale | 16,413 | Sep 17, 2024 | Sept. 18, 2024, 4:18 p.m. |
|
ALHC
|
Sale | 25,000 | Sep 13, 2024 | Sept. 13, 2024, 6:21 p.m. |
|
ALHC
|
Sale | 25,000 | Sep 12, 2024 | Sept. 13, 2024, 6:21 p.m. |
|
ALHC
|
Sale | 24,900 | Jul 17, 2024 | July 19, 2024, 8:27 p.m. |
|
ALHC
|
Sale | 100 | Jul 17, 2024 | July 19, 2024, 8:27 p.m. |
|
ALHC
|
Sale | 2,600 | Jul 12, 2024 | July 16, 2024, 8:29 p.m. |
|
ALHC
|
Sale | 22,400 | Jul 15, 2024 | July 16, 2024, 8:29 p.m. |
|
ALHC
|
Sale | 4,898 | Nov 10, 2023 | Nov. 15, 2023, 9:24 p.m. |
|
ALHC
|
Purchase | 100,000 | Mar 09, 2023 | March 10, 2023, 6 p.m. |
$ALHC Executives and Stock Owners with Insider Trades
-
Robert Thomas Freeman, Chief Financial Officer
-
Dawn Christine Maroney, President, Markets
-
John E Kao, Chief Executive Officer
-
Dinesh M. Kumar, Chief Med & Operating Officer
-
Christopher J Joyce, Chief Legal and Admin. Officer
-
Hakan Kardes, Chief Experience Officer
-
Dinesh M. Kumar, Chief Medical Officer
-
Joseph S Konowiecki, Chairman of the Board
-
Richard A. Cross, SVP, General Counsel
-
Robert L. Scavo, Chief Information Officer
-
Donald Steven Furman, Chief Clinical Officer
-
Hyong Kim, Chief Medical Officer
-
Rajesh Shrestha, Pres., New Markets & CBO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.